Morco (Fluticasone Furoate)

Fluticasone furoate, the active ingredient in Morco, is a glucocorticoid presented as a nasal spray for nasal administration. It is used to treat allergic inflammation of the nasal passages in adults and children with allergic rhinitis, reducing swelling, congestion, and nasal discharge associated with seasonal and perennial triggers.

GNH USA supplies Morco as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our global distribution network ensures consistent quality and regulatory compliance for each batch delivered to healthcare providers.

Morco, a nasal corticosteroid, is indicated for several forms of allergic rhinitis. - Allergic rhinitis: reduces nasal congestion, itching, and rhinorrhea caused by allergic triggers. - Seasonal allergic rhinitis: provides symptom relief during pollen or mold seasons. - Perennial allergic rhinitis: controls chronic nasal symptoms caused by year‑round allergens.

Fluticasone furoate nasal spray may cause local and systemic adverse reactions.

Common Side Effects: - Nasal irritation or burning: mild discomfort at the application site. - Nosebleeds (epistaxis): occasional bleeding from the nasal mucosa. - Headache: transient headache following use. - Dry throat: sensation of dryness after dosing.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rare but may include swelling, hives, and difficulty breathing. - Vision changes: rare cases of cataract or glaucoma with prolonged use. - Suppressed adrenal function: uncommon systemic effect with high‑dose or long‑term therapy.

Before using Morco, consider the following precautions to ensure safe and effective therapy. - Pregnancy: consult a healthcare professional, as safety data are limited. - Concurrent nasal surgery or trauma: avoid use until healing is complete. - Infection: do not use if nasal fungal or bacterial infection is present without medical advice. - Long‑term use: monitor for signs of adrenal suppression or intraocular pressure elevation. - Store at room temperature: keep below 25 °C, protect from moisture and direct sunlight.

Fluticasone furoate may interact with other medicines; awareness of key interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Systemic corticosteroids: concurrent use can increase risk of systemic glucocorticoid effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise local exposure and potential side effects.

Moderate Interactions (Monitor Closely): - Antifungal azoles (e.g., itraconazole): may modestly increase fluticasone levels. - Immunosuppressants (e.g., cyclosporine): monitor for enhanced immunosuppression.